Načítá se...
Outcomes of Oral Metronomic Therapy in Patients with Lymphomas
Oral Metronomic chemotherapy (OMC) is used in patients with lymphoma who may not tolerate intravenous chemotherapy or have refractory disease. It is cheaper, less toxic and easy to administer. Adult patients with lymphoma who received OMC (combination of cyclophosphamide, etoposide and prednisolone)...
Uloženo v:
| Vydáno v: | Indian J Hematol Blood Transfus |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer India
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6369082/ https://ncbi.nlm.nih.gov/pubmed/30828148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-018-0995-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|